{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:24:26Z","timestamp":1760016266467,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jcv.2022.105252","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T06:31:34Z","timestamp":1659594694000},"page":"105252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-3278","authenticated-orcid":false,"given":"Kasper T.","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Pierard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Beuselinck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Bonsall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Nevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoeri","family":"Schrooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Van Wijngaerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lize","family":"Cuypers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel","family":"Van Laethem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2022.105252_bib0001","unstructured":"World Health Organization HCV fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c (accessed August 11, 2022)."},{"key":"10.1016\/j.jcv.2022.105252_bib0002","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3389\/fmicb.2018.00854","article-title":"Evolutionary analysis provides insight into the origin and adaptation of HCV","volume":"9","author":"Forni","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0003","unstructured":"International Committee for the Taxonomy of Viruses, Confirmed HCV genotypes\/subtypes (May 2019), https:\/\/talk.ictvonline.org\/ictv_wikis\/flaviviridae\/w\/sg_flavi\/634\/table-1\u2014confirmed-hcv-genotypes-subtypes-may-2019, (accessed 15 February 2022)."},{"key":"10.1016\/j.jcv.2022.105252_bib0004","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105252_bib0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/JCM.02366-06","article-title":"Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C\/E1 and 5\u2019 untranslated region sequences","volume":"45","author":"Murphy","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0006","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1128\/JCM.00586-13","article-title":"Sequencing Assays for Failed Genotyping with the Versant Hepatitis C Virus Genotype Assay (LiPA), Version 2.0","volume":"51","author":"Larrat","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jiac.2019.08.009","article-title":"Comparison of direct sequencing of the NS5B region with the Versant HCV genotype 2.0 assay for genotyping of viral isolates in Mexico","volume":"26","author":"Uribe-Noguez","year":"2020","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.jcv.2022.105252_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4386-4","article-title":"Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital","volume":"19","author":"Goletti","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105252_bib0009","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/ijmm.2012.1209","article-title":"Comparison of three different HCV genotyping methods: core, NS5B sequence analysis and line probe assay","volume":"31","author":"Cai","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jcv.2022.105252_bib0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/CEOR.S106238","article-title":"Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district","volume":"8","author":"Polilli","year":"2016","journal-title":"Clin. Outcomes Res."},{"key":"10.1016\/j.jcv.2022.105252_bib0011","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1128\/JCM.02390-07","article-title":"Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0","volume":"46","author":"Verbeeck","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0012","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1128\/JCM.01982-06","article-title":"Improvement of hepatitis C virus (HCV) genotype determination with the new version of the INNO-LiPA HCV assay","volume":"45","author":"Bouchardeau","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0013","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.12688\/f1000research.7111.1","article-title":"ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens","volume":"4","author":"Bonsall","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.jcv.2022.105252_bib0014","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-018-2459-9","article-title":"GLUE: a flexible software system for virus sequence data","volume":"19","author":"Singer","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jcv.2022.105252_bib0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1089\/aid.1995.11.1423","article-title":"Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning","volume":"11","author":"Salminen","year":"1995","journal-title":"AIDS Res. Hum. Retroviruses."},{"key":"10.1016\/j.jcv.2022.105252_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/vev003","article-title":"RDP4: Detection and analysis of recombination patterns in virus genomes","volume":"1","author":"Martin","year":"2015","journal-title":"Virus Evol"},{"key":"10.1016\/j.jcv.2022.105252_bib0017","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/nar\/gkh340","article-title":"MUSCLE: multiple sequence alignment with high accuracy and high throughput","volume":"32","author":"Edgar","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcv.2022.105252_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/molbev\/msu300","article-title":"IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies","volume":"32","author":"Nguyen","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.jcv.2022.105252_bib0019","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijid.2021.09.041","article-title":"Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia","volume":"113","author":"Isakov","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105252_bib0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/j.gastro.2019.05.007","article-title":"Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir","volume":"157","author":"Wing","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcv.2022.105252_bib0021","first-page":"1065","article-title":"Efficacy and safety of elbasvir\/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trial","volume":"4","author":"Wei","year":"2020","journal-title":"JGH Open an Open Access J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2022.105252_bib0022","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijid.2017.12.016","article-title":"Hepatitis C virus deep sequencing for sub-genotype identification in mixed infections: A real-life experience","volume":"67","author":"del Campo","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2022.105252_bib0023","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jfma.2011.11.006","article-title":"Detection of hepatitis C virus subtypes 6a, 6n, 6w and mixed infections using a modified multiplex real-time polymerase chain reaction protocol","volume":"110","author":"Lee","year":"2011","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.jcv.2022.105252_bib0024","first-page":"17","article-title":"Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k\/1b Circulating Recombinant Form","author":"Schuermans","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jcv.2022.105252_bib0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/hepr.13587","article-title":"Assessment of treatment options for patients with hepatitis C virus recombinant form 2k\/1b","volume":"51","author":"Zakalashvili","year":"2021","journal-title":"Hepatol. Res."},{"issue":"9","key":"10.1016\/j.jcv.2022.105252_bib0026","first-page":"1","article-title":"Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing","volume":"91","author":"Fern\u00e1ndez-Caso","year":"2019","journal-title":"Sci. Reports"},{"key":"10.1016\/j.jcv.2022.105252_bib0027","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cmi.2017.02.007","article-title":"High HCV subtype heterogeneity in a chronically infected general population revealed by high-resolution hepatitis C virus subtyping","volume":"23","author":"Rodriguez-Frias","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2022.105252_bib0028","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.23885","article-title":"Frequent multiple hepatitis C virus infections among injection drug users in a prison setting","volume":"52","author":"Pham","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2022.105252_bib0029","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00535-018-1429-3","article-title":"The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection","volume":"53","author":"Zeuzem","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105252_bib0030","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2022.105252_bib0031","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3389\/fmicb.2020.576572","article-title":"Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical Pathway","volume":"11","author":"Manso","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.jcv.2022.105252_bib0032","unstructured":"World Health Organization. (2016). Combating hepatitis B and C to reach elimination by 2030: advocacy brief, World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/206453."},{"key":"10.1016\/j.jcv.2022.105252_bib0033","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.3748\/wjg.v24.i44.4959","article-title":"Hepatitis elimination by 2030: Progress and challenges","volume":"24","author":"Waheed","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jcv.2022.105252_bib0034","first-page":"13","article-title":"Global utilization trends of direct acting antivirals (Daas) during the covid-19 pandemic: A time series analysis","author":"Shakeri","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2022.105252_bib0035","unstructured":"PROGRESS REPORT ON ACCESS TO HEPATITIS C TREATMENT FOCUS ON OVERCOMING BARRIERS IN LOW-AND MIDDLE-INCOME COUNTRIES, (2018)."},{"key":"10.1016\/j.jcv.2022.105252_bib0036","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jviromet.2017.10.005","article-title":"A novel next generation sequencing assay as an alternative to currently available methods for hepatitis C virus genotyping","volume":"251","author":"Dirani","year":"2018","journal-title":"J. Virol. Methods."},{"key":"10.1016\/j.jcv.2022.105252_bib0037","doi-asserted-by":"crossref","unstructured":"V. Caputo, R. Antonia Diotti, E. Boeri, H. Hasson, M. Sampaolo, E. Criscuolo, S. Bagaglio, E. Messina, C. Uberti-Foppa, M. Castelli, R. Burioni, N. Mancini, M. Clementi, N. Clementi, Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols, (2020). 10.1186\/s12985-020-01381-3.","DOI":"10.1186\/s12985-020-01381-3"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222001846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653222001846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T20:22:11Z","timestamp":1741810931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653222001846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":37,"alternative-id":["S1386653222001846"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105252","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Full-genome next-generation sequencing of hepatitis C virus to assess the accuracy of genotyping by the commercial assay LiPA and the prevalence of resistance-associated substitutions in a Belgian cohort","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2022.105252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105252"}}